IL283185B2 - Macrolides with 13 members converted to C10-cyclic and their uses - Google Patents

Macrolides with 13 members converted to C10-cyclic and their uses

Info

Publication number
IL283185B2
IL283185B2 IL283185A IL28318521A IL283185B2 IL 283185 B2 IL283185 B2 IL 283185B2 IL 283185 A IL283185 A IL 283185A IL 28318521 A IL28318521 A IL 28318521A IL 283185 B2 IL283185 B2 IL 283185B2
Authority
IL
Israel
Prior art keywords
optionally substituted
alkyl
group
compound
alkylene
Prior art date
Application number
IL283185A
Other languages
English (en)
Hebrew (he)
Other versions
IL283185A (en
IL283185B1 (en
Original Assignee
Zikani Therapeutics Inc
Harvard College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zikani Therapeutics Inc, Harvard College filed Critical Zikani Therapeutics Inc
Publication of IL283185A publication Critical patent/IL283185A/en
Publication of IL283185B1 publication Critical patent/IL283185B1/en
Publication of IL283185B2 publication Critical patent/IL283185B2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/01—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/18—Acyclic radicals, substituted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Pyrane Compounds (AREA)
IL283185A 2018-11-19 2019-11-18 Macrolides with 13 members converted to C10-cyclic and their uses IL283185B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862769413P 2018-11-19 2018-11-19
PCT/US2019/062045 WO2020106636A1 (en) 2018-11-19 2019-11-18 C11-cyclic substituted 13-membered macrolides and uses thereof

Publications (3)

Publication Number Publication Date
IL283185A IL283185A (en) 2021-06-30
IL283185B1 IL283185B1 (en) 2024-02-01
IL283185B2 true IL283185B2 (en) 2024-06-01

Family

ID=68965978

Family Applications (2)

Application Number Title Priority Date Filing Date
IL283185A IL283185B2 (en) 2018-11-19 2019-11-18 Macrolides with 13 members converted to C10-cyclic and their uses
IL310280A IL310280A (en) 2018-11-19 2019-11-18 C10-cyclic substituted 13-membered macrolides and uses thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL310280A IL310280A (en) 2018-11-19 2019-11-18 C10-cyclic substituted 13-membered macrolides and uses thereof

Country Status (12)

Country Link
US (1) US20220177508A1 (cg-RX-API-DMAC10.html)
EP (1) EP3883945A1 (cg-RX-API-DMAC10.html)
JP (1) JP2022507795A (cg-RX-API-DMAC10.html)
KR (1) KR20210123288A (cg-RX-API-DMAC10.html)
CN (1) CN113646319A (cg-RX-API-DMAC10.html)
AU (2) AU2019385383B2 (cg-RX-API-DMAC10.html)
BR (1) BR112021009607A2 (cg-RX-API-DMAC10.html)
CA (1) CA3120235A1 (cg-RX-API-DMAC10.html)
IL (2) IL283185B2 (cg-RX-API-DMAC10.html)
MX (1) MX2021005421A (cg-RX-API-DMAC10.html)
SG (1) SG11202105228SA (cg-RX-API-DMAC10.html)
WO (1) WO2020106636A1 (cg-RX-API-DMAC10.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202313065A (zh) * 2021-05-28 2023-04-01 美商季卡尼醫療公司 用於治療遺傳疾病之化合物
WO2023235380A1 (en) * 2022-06-01 2023-12-07 Zikani Therapeutics, Inc. Macrolides for treating genetic diseases
WO2023250513A1 (en) * 2022-06-24 2023-12-28 Zikani Therapeutics, Inc. 13-membered macrolide compounds for treating diseases mediated by abnormal protein translation
KR20250048331A (ko) * 2022-08-11 2025-04-08 지카니 테라퓨틱스, 인크. 치료용 아자케톨라이드 제조용 합성 공정 및 중간체

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA70972C2 (uk) * 1998-11-20 2004-11-15 Пфайзер Продактс Інк. 13-членні азаліди і їх застосування як антибіотиків
ATE243703T1 (de) * 2000-01-27 2003-07-15 Pfizer Prod Inc Antibiotische azalid-zusammensetzungen
JP4311203B2 (ja) * 2001-08-08 2009-08-12 大正製薬株式会社 11a−アザライド化合物及びその製造方法
WO2004108744A2 (en) * 2003-05-19 2004-12-16 Prasad K Deshpande Azalides and azaketolides having antimicrobial activity
WO2007091393A1 (ja) * 2006-02-07 2007-08-16 Taisho Pharmaceutical Co., Ltd. 10a-アザライド化合物
EP2588084B1 (en) * 2010-07-01 2023-11-22 Elanco Tiergesundheit AG Antibiotic compositions comprising tulathromycin
EP4095146A1 (en) * 2013-04-04 2022-11-30 President And Fellows Of Harvard College Macrolides and methods of their preparation and use
JP2017531663A (ja) * 2014-10-08 2017-10-26 プレジデント アンド フェローズ オブ ハーバード カレッジ 14員ケトライドならびにそれらの調製および使用の方法
WO2016154591A1 (en) * 2015-03-25 2016-09-29 President And Fellows Of Harvard College Macrolides with modified desosamine sugars and uses thereof

Also Published As

Publication number Publication date
IL283185A (en) 2021-06-30
EP3883945A1 (en) 2021-09-29
AU2019385383A1 (en) 2021-07-01
CA3120235A1 (en) 2020-05-28
JP2022507795A (ja) 2022-01-18
IL310280A (en) 2024-03-01
AU2019385383B2 (en) 2023-06-15
AU2023229518A1 (en) 2023-09-28
IL283185B1 (en) 2024-02-01
CN113646319A (zh) 2021-11-12
BR112021009607A2 (pt) 2021-08-10
MX2021005421A (es) 2021-09-21
KR20210123288A (ko) 2021-10-13
WO2020106636A1 (en) 2020-05-28
SG11202105228SA (en) 2021-06-29
US20220177508A1 (en) 2022-06-09

Similar Documents

Publication Publication Date Title
EP3664799B1 (en) Lincosamide antibiotics and uses thereof
US11535643B2 (en) Macrolides with modified desosamine sugars and uses thereof
AU2023229518A1 (en) C10-Cyclic Substituted 13-Membered Macrolides and Uses Thereof
US20260035402A1 (en) C10-alkylene substituted 13-membered macrolides and uses thereof
JP2025000636A (ja) C10-アルキレン置換された13員マクロライド及びそれらの使用
JP2025514802A (ja) リンコサミドおよびその使用
US20230242565A1 (en) Macrolides with Modified Desosamine Sugars and Uses Thereof
HK40063711A (en) C11-cyclic substituted 13-membered macrolides and uses thereof
EA052403B1 (ru) C10-алкилен-замещенные 13-членные макролиды и их применение
HK40063248A (en) C10-alkylene substituted 13-membered macrolides and uses thereof
BR122025025362A2 (pt) Macrolídeos com 13 membros substituídos por c10-alquileno e usos dos mesmos